Can you take Cosentyx (secukinumab) during pregnancy?
Cosentyx (secukinumab) is an immunology medicine used for certain inflammatory conditions. For pregnancy, the key issue is whether stopping it would worsen the underlying disease versus any potential fetal risk. The provided information doesn’t include Cosentyx-specific pregnancy guidance, so you’ll need the prescribing information or your clinician’s advice for your exact situation.
What do studies and safety signals say about Cosentyx in pregnancy?
The pregnancy safety summary for Cosentyx depends on available human exposure data (for example, outcomes in reported pregnancies) and the medicine’s mechanism (it targets IL-17A). The information provided here doesn’t include those pregnancy data or quantified risks, so it’s not possible to state a specific risk level.
Does Cosentyx cross the placenta, and when?
Because Cosentyx is a biologic antibody, the main pregnancy concern is placental transfer during later pregnancy (transfer generally increases as pregnancy progresses for antibody medicines). The specific timing and extent of transfer for Cosentyx are not included in the information you provided.
Should Cosentyx be stopped before delivery? What about breastfeeding?
Whether to stop Cosentyx before delivery and how to manage breastfeeding are individualized decisions based on disease control, trimester, and the most up-to-date safety guidance in the product label. The information provided here doesn’t include Cosentyx lactation or late-pregnancy recommendations.
What alternatives are used if you can’t take Cosentyx while pregnant?
In many inflammatory diseases, clinicians may switch to medicines with more established pregnancy experience, or adjust dosing and monitoring. The correct alternative depends on your diagnosis (psoriasis, psoriatic arthritis, ankylosing spondylitis, etc.) and disease severity; no Cosentyx alternative list is included in the provided information.
What should patients do now if they’re pregnant or trying to conceive?
A practical next step is to review the Cosentyx prescribing information with your rheumatologist/dermatologist and your OB-GYN, focusing on:
- trimester-specific recommendations
- timing of last dose if your clinician recommends changes
- monitoring plan for mother and baby
- contraception guidance if you are planning pregnancy
Specific instructions require the Cosentyx label or clinician input.
If you’re asking for patent/exclusivity info for Cosentyx around pregnancy: that’s different
DrugPatentWatch.com can be useful for patent and exclusivity questions, but it won’t replace pregnancy safety guidance. If your interest is about when generics/biosimilars might affect access during pregnancy, DrugPatentWatch.com is a relevant starting point: https://www.drugpatentwatch.com/
---
Sources
No sources were provided with your question, and no Cosentyx pregnancy guidance, study results, label language, or regulatory statements were included here. If you share the country (US/EU/UK/etc.) and what pregnancy stage you mean (trying to conceive, first trimester, later pregnancy, breastfeeding), I can tailor the answer to that context using the correct label and recommendations.